Antifibrotic agents for liver disease

American Journal of Transplantation

Volumn 6, Issue 1, 2006, Pages 12-19

  Albanis, E ^a   Friedman, S L ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Extracellular matrix; Fibrosis; Hepatitis C; Stellate cell

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA TOCOPHEROL; ANTIFIBROTIC AGENT; ANTIOXIDANT; CAMOSTAT MESILATE; ENDOTHELIN RECEPTOR ANTAGONIST; GAMMA INTERFERON; GLIOTOXIN; IMATINIB; IMMUNOSUPPRESSIVE AGENT; LOSARTAN; PEGINTERFERON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID; RETINOL; RIBAVIRIN; SCATTER FACTOR; SILYMARIN; TRANSFORMING GROWTH FACTOR BETA1; XIAO CHAI HU TANG;

AGE DISTRIBUTION; APOPTOSIS; CELL FATE; CELL PROLIFERATION; CHEMOTAXIS; CHOLESTATIC HEPATITIS; CYTOKINE RELEASE; DISEASE COURSE; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG TARGETING; EXTRACELLULAR MATRIX; FATTY LIVER; FIBROGENESIS; GRAFT SURVIVAL; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; RACE DIFFERENCE; RECIPIENT; RECURRENT DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; STELLATE CELL; DRUG DESIGN; FIBROSIS; LIVER CELL; PATHOLOGY; REVIEW;

DRUG DESIGN; FIBROSIS; HEPATITIS C, CHRONIC; HEPATOCYTES; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION;

EID: 33644850815     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2005.01143.x     Document Type: Short Survey

References (66)

1. Davis GL Albright JE Cook SF Rosenberg DM Projecting future complications of chronic hepatitis C in the United States Liver Transpl 2003 9 331 338
2. Alter MJ Kruszon-Moran D Nainan OV McQuillan GM Gao F Moyer LA et al The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 1999 341 556 562
3. Manns MP McHutchison JG Gordon SC Rustgi VK Shiffman M Reindollar R et al Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 2001 358 958 965
4. Gane EJ Portmann BC Naoumov NV Smith HM Underhill JA Donaldson PT et al Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 1996 334 815 820
5. Adams JM Cory S The Bcl-2 protein family: arbiters of cell survival Science 1998 281 1322 1326
6. Berenguer M Ferrell L Watson J Prieto M Kim M Rayon M et al HCV-related fibrosis progression following liver transplantation: increase in recent years J Hepatol 2000 32 673 684
7. Gane E The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients Liver Transpl 2003 9 S28 S34
8. Neumann UP Berg T Bahra M Puhl G Guckelberger O Langrehr JM et al Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up Transplantation 2004 77 226 231
9. Berenguer M Prieto M Rayon JM Mora J Pastor M Ortiz V et al Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation Hepatology 2000 32 852 858
10. Berenguer M Prieto M San Juan F Rayon JM Martinez F Carrasco D et al Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 2002 36 202 210
11. Forman LM Lewis JD Berlin JA Feldman HI Lucey MR The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 2002 122 889 896
12. Albanis E Friedman SL Hepatic fibrosis. Pathogenesis and principles of therapy Clin Liver Dis 2001 5 315 334 v vi
13. Friedman SL Mechanisms of hepatic fibrosis and therapeutic implications Nat Clin Pract Gastroenterol Hepatol 2004 1 98 105
14. Kweon YO Goodman ZD Dienstag JL Schiff ER Brown NA Burkhardt E et al Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B J Hepatol 2001 35 749 755
15. Poynard T McHutchison J Manns M Trepo C Lindsay K Goodman Z et al Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 2002 122 1303 1313
16. Issa R Zhou X Constandinou CM Fallowfield J Millward-Sadler H Gaca MD et al Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking Gastroenterology 2004 126 1795 1808
17. Pinzani M Milani S Grappone C Weber FJ Gentilini P Abboud HE et al Expression of platelet-derived growth factor in a model of acute liver injury Hepatology 1994 19 701 707
18. Friedman SL Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury J Biol Chem 2000 275 2247 2250
19. Pinzani M Marra F Cytokine receptors and signaling in hepatic stellate cells Semin Liver Dis 2001 21 397 416
20. Olaso E Friedman SL Molecular regulation of hepatic fibrogenesis J Hepatol 1998 29 836 847
21. Bachem MG Riess U Melchior R Sell KM Gressner AM Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells Febs Lett 1989 257 134 137
22. Dooley S Delvoux B Lahme B Mangasser-Stephan K Gressner AM Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts Hepatology 2000 31 1094 1106
23. Rockey DC Hepatic blood flow regulation by stellate cells in normal and injured liver Seminars in Liver Disease 2001 21 337 350
24. Rockey D Chung J Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility J Clin Invest 1995 95 1199 1206
25. Benyon D Arthur MJP Extracellular matrix degradation and the role of stellate cells Semin Liver Dis 2001 21 373 384
26. Iredale JP Stellate cell behavior during resolution of liver injury Semin Liver Dis 2001 21 427 436
27. Iredale JP Benyon RC Pickering J McCullen M Northrop M Pawley S et al Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 1998 102 538 549
28. Gentilini A Marra F Gentilini P Pinzani M Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells J Hepatol 2000 32 227 234
29. Tangkijvanich P Tam SP Yee HF Jr. Wound-induced migration of rat hepatic stellate cells is modulated by endothelin-1 through rho-kinase-mediated alterations in the acto-myosin cytoskeleton Hepatology 2001 33 74 80
30. Friedman SL Arthur MJ Reversing hepatic fibrosis Sci Med 2002 8 194 205
31. Gilmore IT Burroughs A Murray-Lyon IM Williams R Jenkins D Hopkins A et al Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London Gut 1995 36 437 441
32. McGill DB Rakela J Zinsmeister AR Ott BJ A 21-year experience with major hemorrhage after percutaneous liver biopsy Gastroenterology 1990 99 1396 1400
33. Cadranel JF Rufat P Degos F Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF) Hepatology 2000 32 477 481
34. Fried MW Shiffman ML Reddy KR Smith C Marinos G Goncales FL Jr. et al Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 2002 347 975 982
35. Hadziyannis SJ Sette H Jr. Morgan TR Balan V Diago M Marcellin P et al Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 2004 140 346 355
36. Guido M Rugge M Liver biopsy sampling in chronic viral hepatitis Semin Liver Dis 2004 24 89 97
37. Soloway RD Baggenstoss AH Schoenfield LJ Summerskill WH Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy Am J Dig Dis 1971 16 1082 1086
38. Abdi W Millan JC Mezey E Sampling variability on percutaneous liver biopsy Arch Intern Med 1979 139 667 669
39. Maharaj B Maharaj RJ Leary WP Cooppan RM Naran AD Pirie D et al Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1986 1 523 525
40. Baunsgaard P Sanchez GC Lundborg CJ The variation of pathological changes in the liver evaluated by double biopsies Acta Pathol Microbiol Scand [A] 1979 87 51 57
41. Regev A Berho M Jeffers LJ Milikowski C Molina EG Pyrsopoulos NT et al Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 2002 97 2614 2618
42. Rockey DC Chung JJ Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis J Investig Med 1994 42 660 670
43. Ueki T Kaneda Y Tsutsui H et al Hepatocyte growth factor gene therapy of liver cirrhosis in rats Nat Med 1999 5 226 230
44. Galli A Crabb DW Ceni E Salzano R Mello T Svegliati-Baroni G et al Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro Gastroenterology 2002 122 1924 1940
45. Kon K Ikejima K Hirose M Yoshikawa M Enomoto N Kitamura T et al Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride Biochem Biophys Res Commun 2002 291 55 61
46. Marra F Efsen E Romanelli RG Caligiuri A Pastacaldi S Batignani G et al Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells Gastroenterology 2000 119 466 478
47. Houglum K Venkataramani A Lyche K Chojkier M A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C Gastroenterology 1997 113 1069 1073
48. Shimizu I Ma YR Mizobuchi Y Liu F Miura T Nakai Y et al Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats [see comments] Hepatology 1999 29 149 160
49. Druker BJ Sawyers CL Kantarjian H Resta DJ Reese SF Ford JM et al Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N Engl J Med 2001 344 1038 1042
50. Okuno M Moriwaki H Muto Y Kojima S Protease inhibitors suppress TGF-beta generation by hepatic stellate cells J Hepatol 1998 29 1031 1032
51. Nakamura T Sakata R Ueno T Sata M Ueno H Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats Hepatology 2000 32 247 255
52. George J Roulot D Koteliansky VE Bissell DM In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis Proc Natl Acad Sci U S A 1999 96 12719 12724
53. Ruiz-Ortega M Lorenzo O Ruperez M Esteban V Suzuki Y Mezzano S et al Role of the renin-angiotensin system in vascular diseases: expanding the field Hypertension 2001 38 1382 1387
54. Brown NJ Vaughan DE Fogo AB The renin-angiotensin-aldosterone system and fibrinolysis in progressive renal disease Semin Nephrol 2002 22 399 406
55. Gaedeke J Peters H Noble NA Border WA Angiotensin II, TGF-beta and renal fibrosis Contrib Nephrol 2001 135 153 160
56. Ruiz-Ortega M Lorenzo O Suzuki Y Ruperez M Egido J Proinflammatory actions of angiotensins Curr Opin Nephrol Hypertens 2001 10 321 329
57. Arroyo V Bosch J Mauri M Viver J Mas A Rivera F et al Renin, aldosterone and renal haemodynamics in cirrhosis with ascites Eur J Clin Invest 1979 9 69 73
58. Bataller R Gines P Nicolas J et al Angiotensin II induces contraction and proliferation of human hepatic stellate cells Gastroenterology 2000 118 1149 1156
59. Bataller R Gabele E Parsons CJ Morris T Yang L Schoonhoven R et al Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats Hepatology 2005 41 1046 1055
60. Yoshiji H Yoshii J Ikenaka Y Noguchi R Tsujinoue H Nakatani T et al Inhibition of renin-angiotensin system attenuates liver enzyme-altered preneoplastic lesions and fibrosis development in rats J Hepatol 2002 37 22 30
61. Jonsson JR Clouston AD Ando Y Kelemen LI Horn MJ Adamson MD et al Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis Gastroenterology 2001 121 148 155
62. Croquet V Moal F Veal N et al Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension J Hepatol 2002 37 773 780
63. Boffa JJ Lu Y Placier S Stefanski A Dussaule JC Chatziantoniou C et al Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases J Am Soc Nephrol 2003 14 1132 1144
64. Yu Q Shao R Qian HS George SE Rockey DC Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension J Clin Invest 2000 105 741 748
65. Salgado S Garcia J Vera J Siller F Bueno M Miranda A et al Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy Mol Ther 2000 2 545 551
66. Wright M Issa R Smart D et al Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats Gastroenterology 2001 121 685 698